Mergers & Acquisitions

The independent existence of CureVac could soon be a chapter in corporate history. On November 25, shareholders will convene in...

The departure of sales chief Rick Mahoney has cast a shadow over Synopsys during a critical phase for the semiconductor...

In a strategic move that signals a profound shift in its financial operations, PayPal has dramatically expanded its existing arrangement...

A biotech firm suddenly flush with cash and developing a revolutionary medical treatment typically represents an investor's ideal scenario. However,...

A contentious battle is unfolding among Tiptree's investors as the company moves forward with plans to sell its insurance subsidiary...

Investors in Akero Therapeutics are bracing for a pivotal moment as the biopharmaceutical company approaches a decisive regulatory deadline. With...

Rumble finds itself at a critical crossroads. As its stock plummets to unprecedented lows, the video platform operator is making...

While AP Moeller-Maersk's shares have recently faced pressure, the Danish logistics conglomerate is making substantial strategic moves to position itself...

A legal dispute that first emerged seventeen years ago in India has resurfaced, potentially exposing Motorola Solutions to unexpected billions...

As the global energy sector undergoes a fundamental transformation, Exxon Mobil is demonstrating a dual-track strategy. The oil giant is...